Gaza's cancer patients: Navigating the dual struggle of illness and war
Baroness Delyth Morgan talks to ecancertv at NCRI 2015 about the work of cancer charity Breast Cancer Now.
The charity funds around a third of breast cancer research in the UK and campaigns on breast cancer related issues such as access to new drugs.
NCRI 2015
The work of charity Breast Cancer Now
Baroness Delyth Morgan of Drefelin, Wales, UK
Breast Cancer Now is a new charity formed out of the merger of Breakthrough Breast Cancer and Breast Cancer Campaign. We fund about a third of research in the UK into breast cancer, from open access research grants, from PhD studentships or research fellows through to a research centre at the Institute of Cancer Research. So quite a broad range of research activities. We also provide health information and advice and campaign around issues of concern to people affected by breast cancer. One of the big issues of the moment is access to drugs, so whether you’re talking about the very new and innovative treatments that are at the more expensive end of the spectrum that are made available or not through the Cancer Drug Fund, or whether you’re looking at repurposed drugs like bisphosphonates that are off patent and potentially very cheap but still not getting through to the patients who might benefit. So those are the kinds of areas that we might campaign on. We’re a new, growing charity and it’s great to have brought two research charities together and to start with this new initiative. It’s been very, very positively received by all those who care about breast cancer.
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
Grand Rounds: Improving quality of patient-centred care
Special Issue on paediatric oncology
The quantification of cancer medicines in Zambia
CAR-T therapy and impact to cancer patient outcomes and experience of treatment
Supporting breast cancer patients in Vietnam
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Decision making in paediatric oncology